This is an HTML version of an attachment to the Freedom of Information request 'All documents related to Nathan Bock and being cleared by ASADA.'.


 
 
 
 
 
The World Anti-Doping Code 
 
 

 
 
 
THE 2010 
PROHIBITED LIST 
 
 
INTERNATIONAL 
STANDARD  
 
 
 
 
 
 
 
 
The official text of the Prohibited List shall be maintained by WADA and shall be 
published in English and French. In the event of any conflict between the English 
and French versions, the English version shall prevail. 
 
 
 
 

This List shall come into effect on 1 January 2010 
The Prohibited List 2010 
19 September 2009 

 
THE 2010 PROHIBITED LIST 
WORLD ANTI-DOPING CODE  
 
Valid 1 January 2010 
 
 
 
All Prohibited Substances shall be considered as “Specified 
Substances” except Substances in classes S1, S2.1 to S2.5, 
S.4.4 and S6.a, and Prohibited Methods M1, M2 and M3.  
 
 
SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES 
(IN- AND OUT-OF-COMPETITION) 
 
PROHIBITED SUBSTANCES 
 
S1. ANABOLIC AGENTS 
 
Anabolic agents are prohibited. 
 
1.  Anabolic Androgenic Steroids (AAS) 
 
a. Exogenous* AAS, including:  
 
1-androstendiol (5α-androst-1-ene-3β,17β-diol ); 1-androstendione (5α-
androst-1-ene-3,17-dione); bolandiol (19-norandrostenediol); bolasterone; 
boldenone; boldione 
(androsta-1,4-diene-3,17-dione); calusterone; 
clostebol; danazol 
(17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazole)
dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-
1,4-dien-3-one);  desoxymethyltestosterone (17α-methyl-5α-androst-2-en-
17β-ol); drostanolone; ethylestrenol (19-nor-17α-pregn-4-en-17-ol)
fluoxymesterone; formebolone; furazabol 
(17β-hydroxy-17α-methyl-5α-
androstano[2,3-c]-furazan); gestrinone; 4-hydroxytestosterone (4,17β-
dihydroxyandrost-4-en-3-one); mestanolone; mesterolone; metenolone; 
methandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
methandriol; methasterone 
(2α, 17α-dimethyl-5α-androstane-3-one-17β-ol)
methyldienolone 
(17β-hydroxy-17α-methylestra-4,9-dien-3-one); methyl-1-
testosterone 
(17β-hydroxy-17α-methyl-5α-androst-1-en-3-one)
methylnortestosterone 
(17β-hydroxy-17α-methylestr-4-en-3-one)
methyltestosterone; metribolone (methyltrienolone, 17β-hydroxy-17α-
methylestra-4,9,11-trien-3-one); mibolerone; nandrolone; 19-
norandrostenedione 
(estr-4-ene-3,17-dione); norboletone; norclostebol; 
norethandrolone; oxabolone; oxandrolone; oxymesterone; oxymetholone; 
prostanozol 
(17β-hydroxy-5α-androstano[3,2-c] pyrazole); quinbolone; 
The Prohibited List 2010 
 

19 September 2009 

 
stanozolol; stenbolone; 1-testosterone (17β-hydroxy-5α-androst-1-en-3-
one); tetrahydrogestrinone (18a-homo-pregna-4,9,11-trien-17β-ol-3-one)
trenbolone 
and other substances with a similar chemical structure or similar 
biological effect(s). 
 
 
b. Endogenous** AAS when administered exogenously: 
 
androstenediol 
(androst-5-ene-3β,17β-diol); androstenedione (androst-4-ene-
3,17-dione); dihydrotestosterone (17β-hydroxy-5α-androstan-3-one) 
prasterone (dehydroepiandrosterone, DHEA); testosterone 
and the following metabolites and isomers: 
 
5α-androstane-3α,17α-diol; 5α-androstane-3α,17β-diol; 5α-androstane-
3β,17α-diol; 5α-androstane-3β,17β-diol; androst-4-ene-3α,17α-diol; 

androst-4-ene-3α,17β-diol; androst-4-ene-3β,17α-diol; androst-5-ene-
3α,17α-diol; androst-5-ene-3α,17β-diol; androst-5-ene-3β,17α-diol; 
4-androstenediol 
(androst-4-ene-3β,17β-diol); 5-androstenedione (androst-
5-ene-3,17-dione); epi-dihydrotestosterone; epitestosterone; 3α-hydroxy-
5α-androstan-17-one; 3β-hydroxy-5α-androstan-17-one; 19-
norandrosterone; 19-noretiocholanolone. 

 
 
2.  Other Anabolic Agents, including but not limited to: 

 
Clenbuterol, selective androgen receptor modulators (SARMs), tibolone, 
zeranol, zilpaterol. 
 
For purposes of this section: 
“exogenous” refers to a substance which is not ordinarily capable of being 
produced by the body naturally.
 
** “endogenous” refers to a substance which is capable of being produced by the 
body naturally.
 
 
 
 
S2. PEPTIDE HORMONES, GROWTH FACTORS AND RELATED 
SUBSTANCES 

 
The following substances and their releasing factors are prohibited: 
 

1.  Erythropoiesis-Stimulating Agents [e.g. erythropoietin (EPO), 
darbepoetin (dEPO), methoxy polyethylene glycol-epoetin beta 
(CERA), hematide];
  
2.  Chorionic Gonadotrophin (CG) and Luteinizing Hormone (LH) in 
males; 
3.  Insulins; 
4.  Corticotrophins; 

The Prohibited List 2010 
 

19 September 2009 

 
5.  Growth Hormone (GH), Insulin-like Growth Factor-1 (IGF-1), 
Mechano Growth Factors (MGFs), Platelet-Derived Growth Factor 
(PDGF), Fibroblast Growth Factors (FGFs), Vascular-Endothelial 
Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF) 
as well 
as any other growth factor affecting muscle, tendon or ligament protein 
synthesis/degradation, vascularisation, energy utilization, regenerative 
capacity or fibre type switching;  
6.  Platelet-derived preparations (e.g. Platelet Rich Plasma, “blood 
spinning”) administered by intramuscular route.  Other routes of 
administration require a declaration of Use in accordance with the 
International Standard for Therapeutic Use Exemptions. 
 
and other substances with similar chemical structure or similar biological 
effect(s). 
 
 
 
S3. BETA-2 AGONISTS 
 
All beta-2 agonists (including both optical isomers where relevant) are prohibited 
except salbutamol (maximum 1600 micrograms over 24 hours) and salmeterol by 
inhalation which require a declaration of Use in accordance with the International 
Standard for Therapeutic Use Exemptions. 
 
The presence of salbutamol in urine in excess of 1000 ng/mL is presumed not to 
be an intended therapeutic use of the substance and will be considered as an 
Adverse Analytical Finding unless the Athlete proves, through a controlled 
pharmacokinetic study, that the abnormal result was the consequence of the use 
of a therapeutic dose (maximum 1600 micrograms over 24 hours) of inhaled 
salbutamol. 
 
 
 
S4. HORMONE ANTAGONISTS AND MODULATORS 
 
The following classes are prohibited: 
 
1.  Aromatase inhibitors including, but not limited to: aminoglutethimide, 
anastrozole, androsta-1,4,6-triene-3,17-dione 
(androstatrienedione), 4-androstene-3,6,17 trione (6-oxo), 
exemestane, formestane, letrozole, testolactone. 

 
2.  Selective estrogen receptor modulators (SERMs) 
including, but not 
limited to: raloxifene, tamoxifen, toremifene. 
 
3.  Other anti-estrogenic substances including, but not limited to: 
clomiphene, cyclofenil, fulvestrant. 
 
The Prohibited List 2010 
 

19 September 2009 

 
4.  Agents modifying myostatin function(s) including but not limited to: 
myostatin inhibitors.  
 
 
 
S5. DIURETICS AND OTHER MASKING AGENTS 

 
Masking agents are prohibited.  They include:  
Diuretics, probenecid, plasma expanders (e.g. glycerol; intravenous 
administration of albumin, dextran, hydroxyethyl starch and mannitol) and 
other substances with similar biological effect(s). 
 
Diuretics include: 
Acetazolamide, amiloride, bumetanide, canrenone, chlorthalidone, 
etacrynic acid, furosemide, indapamide, metolazone, spironolactone, 
thiazides (
e.g. bendroflumethiazide, chlorothiazide, hydrochlorothiazide), 
triamterene
, and other substances with a similar chemical structure or similar 
biological effect(s) (except drosperinone, pamabrom and topical dorzolamide and 
brinzolamide, which are not prohibited). 
 
A Therapeutic Use Exemption for diuretics and masking agents is not valid if an 
Athlete’s urine contains such substance(s) in association with threshold or sub-
threshold levels of an exogenous Prohibited Substance(s) 
The Prohibited List 2010 
 

19 September 2009 

 
PROHIBITED METHODS 
 
 
M1. ENHANCEMENT OF OXYGEN TRANSFER 
 
The following are prohibited: 
 
1.  Blood doping, including the use of autologous, homologous or heterologous 
blood or red blood cell products of any origin.  
 
2.  Artificially enhancing the uptake, transport or delivery of oxygen, including 
but not limited to perfluorochemicals, efaproxiral (RSR13) and modified 
haemoglobin products (e.g. haemoglobin-based blood substitutes, 
microencapsulated haemoglobin products), excluding supplemental oxygen. 
 
 
 
M2. CHEMICAL AND PHYSICAL MANIPULATION 
 
1.  Tampering, or attempting to tamper, in order to alter the integrity and 
validity of Samples collected during Doping Controls is prohibited.  These 
include but are not limited to catheterisation, urine substitution and/or 
adulteration (e.g. proteases). 
 
2.   Intravenous infusions are prohibited except for those legitimately received in 
the course of hospital admissions or clinical investigations.       
 
 
M3. GENE DOPING 
 
The following, with the potential to enhance athletic performance, are prohibited: 
 
1-  The transfer of cells or genetic elements (e.g. DNA, RNA);   
 
2-  The use of pharmacological or biological agents that alter gene expression.  
 
 
Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists (e.g. GW 1516) 
and PPARδ-AMP-activated protein kinase (AMPK) axis agonists (e.g. AICAR) are 
prohibited. 
 
 
The Prohibited List 2010 
 

19 September 2009 

 
SUBSTANCES AND METHODS 
PROHIBITED IN-COMPETITION 
 
 
In addition to the categories S1 to S5 and M1 to M3 defined above, 
the following categories are prohibited in competition: 
 
 

PROHIBITED SUBSTANCES 
 
S6. STIMULANTS 
 
All stimulants (including both optical isomers where relevant) are prohibited, 
except imidazole derivatives for topical use and those stimulants included in the 
2010 Monitoring Program*. 
 
Stimulants include:  
 
a: Non-Specified Stimulants: 
 
Adrafinil; amfepramone; amiphenazole; amphetamine; amphetaminil; 
benfluorex; benzphetamine; benzylpiperazine; bromantan; clobenzorex; 
cocaine; cropropamide; crotetamide; dimethylamphetamine; 
etilamphetamine; famprofazone; fencamine; fenetylline; fenfluramine; 

fenproporex; furfenorex; mefenorex; mephentermine; mesocarb; 
methamphetamine(d-); p-methylamphetamine; 
methylenedioxyamphetamine; methylenedioxymethamphetamine; 
methylhexaneamine (dimethylpentylamine); modafinil; norfenfluramine; 
phendimetrazine; phenmetrazine; phentermine; 4-phenylpiracetam 
(carphedon); prenylamine; prolintane.   

A stimulant not expressly listed in this section is a Specified Substance. 
 
b: Specified Stimulants (examples): 
 
Adrenaline**; cathine***; ephedrine****; etamivan; etilefrine; fenbutrazate; 
fencamfamin; heptaminol; isometheptene; levmetamphetamine; 

meclofenoxate; methylephedrine****; methylphenidate; nikethamide; 
norfenefrine; octopamine; oxilofrine; parahydroxyamphetamine; 
pemoline; pentetrazol; phenpromethamine; propylhexedrine; 
pseudoephedrine*****; selegiline; sibutramine; strychnine; 
tuaminoheptane
 and other substances with a similar chemical structure or 
similar biological effect(s).   
 
 
The Prohibited List 2010 
 

19 September 2009 

 
* The following substances included in the 2010 Monitoring Program (bupropion, 
caffeine, phenylephrine, phenylpropanolamine, pipradol, synephrine) are not 
considered as Prohibited Substances. 
** Adrenaline associated with local anaesthetic agents or by local administration 
(e.g. nasal, ophthalmologic) is not prohibited. 
*** Cathine is prohibited when its  concentration in urine is greater than 5 
micrograms per milliliter.   
**** Each of ephedrine  and methylephedrine is prohibited when its 
concentration in urine is greater than 10 micrograms per milliliter.  
*****  Pseudoephedrine  is prohibited when its concentration in urine is greater 
than 150 micrograms per milliliter.   
 
 
S7. NARCOTICS 
 
The following narcotics are prohibited: 
 
Buprenorphine, dextromoramide, diamorphine (heroin), fentanyl and its 

derivatives, hydromorphone, methadone, morphine, oxycodone, 
oxymorphone, pentazocine, pethidine. 
 
 
 
S8. CANNABINOIDS 
 
Natural or synthetic Δ9-tetrahydrocannabinol (THC) and THC-like cannabinoids 
(e.g. hashish, marijuana, HU-210) are prohibited. 
 
 
 
S9. GLUCOCORTICOSTEROIDS 

 
All glucocorticosteroids are prohibited when administered by oral, intravenous, 
intramuscular or rectal routes.  
 
In accordance with the International Standard for Therapeutic Use Exemptions, a 
declaration of Use must be completed by the Athlete for glucocorticosteroids 
administered by intraarticular, periarticular, peritendinous, epidural, intradermal 
and inhalation routes, except as noted below.  
 
Topical preparations when used for auricular, buccal, dermatological (including 
iontophoresis/phonophoresis), gingival, nasal, ophthalmic and perianal disorders 
are not prohibited and require neither a Therapeutic Use Exemption nor a 
declaration of Use
 
The Prohibited List 2010 
 

19 September 2009 

 
 
 

SUBSTANCES PROHIBITED IN PARTICULAR 
SPORTS 
 
P1. ALCOHOL 

 
Alcohol (ethanol) is prohibited In-Competition only, in the following sports. 
Detection will be conducted by analysis of breath and/or blood. The doping 
violation threshold (haematological values) is 0.10 g/L. 
 
  Aeronautic (FAI)  
  
  Modern Pentathlon (UIPM)  for 
  Archery (FITA) 
 
disciplines involving shooting 
  Automobile (FIA) 
 
  
  Motorcycling (FIM) 
 
  Karate (WKF)              
  Ninepin and Tenpin Bowling (FIQ) 
 
  Powerboating (UIM) 
 
     
 
 
 
P2. BETA-BLOCKERS 
 
Unless otherwise specified, beta-blockers are prohibited In-Competition only, in 
the following sports.  
 
  Aeronautic (FAI) 
  Modern Pentathlon (UIPM) for 
  Archery (FITA) (also prohibited 
disciplines involving shooting 
Out-of-Competition
  Ninepin and Tenpin Bowling (FIQ) 
  Automobile (FIA) 
  Powerboating (UIM) 
  Billiards and Snooker (WCBS) 
  Sailing (ISAF) for match race 
  Bobsleigh (FIBT) 
helms only  
  Boules (CMSB) 
  Shooting (ISSF, IPC) (also 
  Bridge (FMB) 
prohibited Out-of-Competition
  Curling (WCF) 
  Skiing/Snowboarding (FIS) in ski 
  Golf (IGF) 
jumping, freestyle aerials/halfpipe 
  Gymnastics (FIG) 
and snowboard halfpipe/big air 
  Motorcycling (FIM) 
  Wrestling (FILA)
 
 
 
Beta-blockers include, but are not limited to, the following: 
 
Acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol, 
carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol, 
metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol. 
 
 
 
 
The Prohibited List 2010 
 

19 September 2009